As we'll soon start to see the results of the first vaccines coming through late-stage clinical trials, Jeremy Farrar explains why we should be cautiously optimistic.
As global efforts continue to make sure COVID-19 tests, treatments and vaccines are available to those who need them the most, Will Hall writes about the importance of a coordinated global response, delivered locally.
Six months on from the first case of COVID-19, the pandemic is accelerating and spreading into new areas. Jeremy Farrar talks about the lessons we learned and the long-term solutions.
Effective treatments, that are accessible to everyone who needs them, have to be part of the solution to the coronavirus pandemic – here's why.
Researchers may well identify a safe, effective vaccine for COVID-19 before too long, but all that fantastic work could count for nothing unless we also invest in the next stages of the vaccine process – manufacturing and delivery.
With measures to prevent the spread of COVID-19 disrupting immunisation around the globe, millions are now at risk of other deadly diseases. We must act and invest urgently to maintain routine immunisation.
On 4 May, world leaders and health organisations pledged billions for the COVID-19 response. Alex Harris explains that urgent funding gaps remain for research.
From access to tests, treatments and vaccines for everyone to coordinating urgent action – Alex Harris shares five key messages ahead of the Coronavirus Global Response Summit.
As COVID-19 continues to spread around the world, a global community of researchers are working to find out more about the virus and assess what research needs to be done to stop it.
Only when we have tools to detect, treat and prevent coronavirus disease everywhere, will we be able to stop the pandemic. Developing these tools requires new global partnerships and cooperation.